AGP Executive Report
Last update: 2 hours agoMeasles comeback: The CDC reports U.S. measles cases hit a 35-year high—2,318 so far in 2026, already topping all of 2025—with vaccination rates among kindergarteners falling to 92.5% and kids under 5 driving most of the burden. GLP-1 access shift: Medicare launched a GLP-1 Bridge Program (July 1, 2026–Dec. 31, 2027) to cover weight-loss GLP-1s for Part D beneficiaries, aiming to close a long-standing coverage gap. Safety warnings on weight-loss drugs: Researchers warn that cheaper knockoff/compounded GLP-1s may carry serious risks because they aren’t reviewed like FDA-approved products. Foodborne parasite alert: The CDC is sending “disease detectives” to Ohio as cyclospora cases surge; the outbreak has expanded to nine states. FDA recalls: The FDA announced a voluntary recall of certain generic cetirizine lots after possible cross-contamination with ranitidine, and Amy’s Kitchen recalled specific soup cans over a pull-tab manufacturing issue. Policy pressure on costs: CMS is scrutinizing the AMA’s CPT billing-code influence, raising questions about how coding affects physician payment and health costs. Health-care workforce/coverage stress: A new Medicare/retirement-focused piece highlights how stroke survivors can face major out-of-pocket costs when long-term custodial care isn’t covered.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
